Latest market price
13.86
+0.23+1.69%
OverviewShort InterestFilings
TRVIQT39Trevi Therapeutics, Inc.·NASDAQ
13.86+1.69%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Sep 17, 20264Statement of changes in beneficial ownership
Aug 06, 20268-KCurrent report
Aug 06, 2026S-8Registration of employee benefit securities
Aug 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 202610-QQuarterly report
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20268-KCurrent report
Jun 04, 20264Statement of changes in beneficial ownership
May 07, 2026SC 13D/ABeneficial ownership statement (active, amended)
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 05, 20268-KCurrent report
May 05, 202610-QQuarterly report
Apr 21, 2026ARSAnnual report to shareholders
Apr 21, 2026DEF 14ADefinitive proxy statement
Apr 21, 2026DEFA14AAdditional proxy soliciting materials
Apr 17, 2026424B5Prospectus
Apr 17, 20268-KCurrent report
Apr 16, 2026424B5Prospectus
Apr 10, 2026PRE 14APreliminary proxy statement
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 17, 20268-KCurrent report
#1 / 25 of 351
Page
▼
/ 15